Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M601577200 on May 22, 2006 Originally published In Press as doi:10.1074/jbc.M601577200 on May 19, 2006

J. Biol. Chem., Vol. 281, Issue 29, 20085-20094, July 21, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/29/20085    most recent
M601577200v2
M601577200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotova, O.
Right arrow Articles by Chibalin, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotova, O.
Right arrow Articles by Chibalin, A. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiotonic Steroids Stimulate Glycogen Synthesis in Human Skeletal Muscle Cells via a Src- and ERK1/2-dependent Mechanism*

Olga Kotova{ddagger}, Lubna Al-Khalili{ddagger}, Sara Talia{ddagger}, Catherine Hooke{ddagger}, Olga V. Fedorova§, Alexei Y. Bagrov§, and Alexander V. Chibalin{ddagger}1

From the {ddagger}Section of Integrative Physiology, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 77 Stockholm, Sweden and the §Laboratory of Cardiovascular Science, NIA, National Institutes of Health, Baltimore, Maryland 21224

The cardiotonic steroid, ouabain, a specific inhibitor of Na+,K+-ATPase, initiates protein-protein interactions that lead to an increase in growth and proliferation in different cell types. We explored the effects of ouabain on glucose metabolism in human skeletal muscle cells (HSMC) and clarified the mechanisms of ouabain signal transduction. In HSMC, ouabain increased glycogen synthesis in a concentration-dependent manner reaching the maximum at 100 nM. The effect of ouabain was additive to the effect of insulin and was independent of phosphatidylinositol 3-kinase inhibitor LY294002 but was abolished in the presence of a MEK1/2 inhibitor (PD98059) or a Src inhibitor (PP2). Ouabain increased Src-dependent tyrosine phosphorylation of {alpha}1- and {alpha}2-subunits of Na+,K+-ATPase and promoted interaction of {alpha}1- and {alpha}2-subunits with Src, as assessed by co-immunoprecipitation with Src. Phosphorylation of ERK1/2 and GSK3{alpha}/beta, as well as p90rsk activity, was increased in response to ouabain in HSMC, and these responses were prevented in the presence of PD98059 and PP2. Incubation of HSMC with 100 nM ouabain increased phosphorylation of the{alpha}-subunits of the Na-pump at a MAPK-specific Thr-Pro motif. Ouabain treatment decreased the surface abundance of {alpha}2-subunit, whereas abundance of the {alpha}1-subunit was unchanged. Marinobufagenin, an endogenous vertebrate bufadienolide cardiotonic steroid, increased glycogen synthesis in HSMC at 10 nM concentration, similarly to 100 nM ouabain. In conclusion, ouabain and marinobufagenin stimulate glycogen synthesis in skeletal muscle. This effect is mediated by activation of a Src-, ERK1/2-, p90rsk-, and GSK3-dependent signaling pathway.


Received for publication, February 17, 2005 , and in revised form, April 18, 2006.

* This work was supported by grants from the Swedish Research Council, the Swedish Heart and Lung Foundation, the Novo-Nordisk Foundation, the Swedish Society of Medicine, and the NIA, National Institutes of Health Intramural Research Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Molecular Medicine and Surgery, Section of Integrative Physiology, Karolinska Institutet, von Eulers väg 4, 4 tr, SE-171 77, Stockholm, Sweden. Tel.: 46-8-524-87-584; Fax: 46-8-335436; E-mail: Alexander.Chibalin{at}ki.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Tian, X. Li, M. Liang, L. Liu, J. X. Xie, Q. Ye, P. Kometiani, M. Tillekeratne, R. Jin, and Z. Xie
Changes in Sodium Pump Expression Dictate the Effects of Ouabain on Cell Growth
J. Biol. Chem., May 29, 2009; 284(22): 14921 - 14929.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. V. Fedorova, V. Raju, N. El-Okdi, A. Shidyak, D. J. Kennedy, S. Vetteth, D. R. Giovannucci, A. Y. Bagrov, O. V. Fedorova, J. I. Shapiro, et al.
The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F922 - F934.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Clausen
Regulatory role of translocation of Na+-K+ pumps in skeletal muscle: hypothesis or reality?
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E727 - E728.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. V. Chibalin and B. Benziane
Reply to Clausen letter
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E729 - E729.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Benziane and A. V. Chibalin
Frontiers: Skeletal muscle sodium pump regulation: a translocation paradigm
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E553 - E558.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Mandal, N. A. Delamere, and M. Shahidullah
Ouabain-induced stimulation of sodium-hydrogen exchange in rat optic nerve astrocytes
Am J Physiol Cell Physiol, July 1, 2008; 295(1): C100 - C110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. J. Khundmiri, V. Amin, J. Henson, J. Lewis, M. Ameen, M. J. Rane, and N. A. Delamere
Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway
Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1171 - C1180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Tamiya, M. C. Okafor, and N. A. Delamere
Purinergic agonists stimulate lens Na-K-ATPase-mediated transport via a Src tyrosine kinase-dependent pathway
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C790 - C796.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement